Head Of US FDA Says ‘No Reason’ DEA Should Delay Cannabis Rescheduling

FDA Chief Urges DEA to Expedite Cannabis Rescheduling Decision. The head of the US Food and Drug Administration (FDA), Robert Califf, told elected officials this week that he believes there is ‘no reason for the DEA to delay’ making its decision on cannabis rescheduling. During an hours-long hearing